0001209191-20-027894.txt : 20200508
0001209191-20-027894.hdr.sgml : 20200508
20200508162201
ACCESSION NUMBER: 0001209191-20-027894
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200506
FILED AS OF DATE: 20200508
DATE AS OF CHANGE: 20200508
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Parini Michael
CENTRAL INDEX KEY: 0001661567
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 20860902
MAIL ADDRESS:
STREET 1: C/O VERTEX PHARMACEUTICALS, INC.
STREET 2: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-05-06
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001661567
Parini Michael
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
0
1
0
0
EVP, Chief Adm, Leg & BD Off
Common Stock
2020-05-06
4
M
0
1222
155.57
A
28060
D
Common Stock
2020-05-06
4
S
0
273
270.16
D
27787
D
Common Stock
2020-05-06
4
S
0
140
271.64
D
27647
D
Common Stock
2020-05-06
4
S
0
319
273.00
D
27328
D
Common Stock
2020-05-06
4
S
0
420
273.96
D
26908
D
Common Stock
2020-05-06
4
S
0
70
274.73
D
26838
D
Stock Option (Right to Buy)
155.57
2020-05-06
4
M
0
1222
0.00
D
2028-02-05
Common Stock
1222
8561
D
Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $270.16 (range $269.77 to $270.75).
Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $271.64 (range $271.55 to $271.73).
Open market sales reported on this line occurred at a weighted average price of $273.00 (range $272.66 to $273.44).
Open market sales reported on this line occurred at a weighted average price of $273.96 (range $273.68 to $274.31).
The option vests in 16 quarterly installments from 02/06/2018.
/s/ Sabrina Yohai, Attorney-in-Fact
2020-05-08